202 related articles for article (PubMed ID: 21742301)
1. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
[TBL] [Abstract][Full Text] [Related]
2. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
[TBL] [Abstract][Full Text] [Related]
3. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
[TBL] [Abstract][Full Text] [Related]
4. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
Spieth K; Gille J; Kaufmann R
Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
[TBL] [Abstract][Full Text] [Related]
5. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
Nofal A; Alakad R; Wahid R; Hoseiny HAM
Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant intralesional methotrexate in cutaneous squamous cell carcinoma: a comparative cohort study.
Salido-Vallejo R; Cuevas-Asencio I; Garnacho-Sucedo G; González-Menchen A; Alcántara-Reifs C; De la Corte-Sánchez S; Vélez A; Moreno-Giménez JC
J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1120-4. PubMed ID: 26369617
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant intralesional methotrexate before surgery in squamous cell carcinoma.
Plascencia-Gomez A; Calderón-Rocher C; Proy-Trujillo H; Moreno-Coutiño G
Dermatol Surg; 2014 May; 40(5):584-6. PubMed ID: 24517391
[No Abstract] [Full Text] [Related]
8. [High-dose multimodal radiotherapy of confluent destructively growing aggregated keratoacanthoma. 2 case reports].
Grevelhörster T; Micke O; Hampel G; Schönekaes K; Willich N
Strahlenther Onkol; 1996 Jul; 172(7):395-400. PubMed ID: 8693406
[TBL] [Abstract][Full Text] [Related]
9. Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg.
Thiele JJ; Ziemer M; Fuchs S; Elsner P
Dermatol Surg; 2004 Dec; 30(12 Pt 2):1556-60. PubMed ID: 15606840
[TBL] [Abstract][Full Text] [Related]
10. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
Moss M; Weber E; Hoverson K; Montemarano AD
Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
[TBL] [Abstract][Full Text] [Related]
11. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
Aubut N; Alain J; Claveau J
J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of intralesional methotrexate in specific cutaneous involvement of B-cell chronic lymphocytic leukaemia.
Anyfantakis V; Dammak A; Wierzbicka-Hainaut E; Camus M; Osdoit S; Levilain P; Guillet G
J Eur Acad Dermatol Venereol; 2010 Jul; 24(7):856. PubMed ID: 19943835
[No Abstract] [Full Text] [Related]
13. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
de Visscher JG; van der Wal KG; Blanken R; Willemse F
J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
[No Abstract] [Full Text] [Related]
14. Intralesional methotrexate in keratoacanthoma of the nose.
Hurst LN; Gan BS
Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
[TBL] [Abstract][Full Text] [Related]
15. Treatment of keratoacanthomas with intralesional methotrexate.
Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
[TBL] [Abstract][Full Text] [Related]
16. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant intralesional methotrexate before surgical treatment of invasive squamous cell carcinoma of the lower lip.
Salido-Vallejo R; Garnacho-Saucedo G; Sánchez-Arca M; Moreno-Giménez JC
Dermatol Surg; 2012 Nov; 38(11):1849-50. PubMed ID: 22861167
[No Abstract] [Full Text] [Related]
18. Eruptive Keratoacanthomas in a Red Tattoo.
Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
[No Abstract] [Full Text] [Related]
19. Cutaneous Ultrasound for Tumor Thickness Measurement in Squamous Cell Carcinoma: The Effect of Neoadjuvant Intralesional Methotrexate in 40 Patients.
Bergón-Sendín M; Pulido-Pérez A; Carretero López F; Díez-Sebastián J; Suárez-Fernández R
Dermatol Surg; 2020 Apr; 46(4):530-536. PubMed ID: 31517661
[TBL] [Abstract][Full Text] [Related]
20. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
